REG - FTSE Russell Celadon Pharma. PLC - Celadon Pharmaceuticals

Celadon PharmaceuticalsAnnouncement

05/08/2025 18:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250805:nRSE0951Ua&default-theme=true

RNS Number : 0951U  FTSE Russell  05 August 2025

 

Celadon Pharmaceuticals (UK): Constituent Deletion

Changes in FTSE UK Index Series

05 August 2025

 Following the continued suspension and expected cancellation of trading on AIM
 for Celadon Pharmaceuticals (UK, constituent), please see details of affected
 indexes and effective dates below:

 

 Index                     Effective From

Start of Trading
 FTSE AIM All-Share Index  08 August 2025

 

 

 

 For further information please contact FTSE Russell Client Services at
 info@ftserussell.com (mailto:info@ftserussell.com) or call:

Australia  +61 (0) 2 7228 5659
 Hong Kong  +852 2164 3333
 Japan      +81 3 6441 1430
 London     +44 (0) 20 7866 1810
 New York   +1877 503 6437

Alternatively, please visit our website at lseg.com/ftse-russell
 (https://www.lseg.com/en/ftse-russell)

 Terms of Use (http://www.ftserussell.com/legal/website-terms-use) | Copyright
 © 2025 FTSE Russell

Alternatively, please visit our website at lseg.com/ftse-russell
(https://www.lseg.com/en/ftse-russell)

Terms of Use (http://www.ftserussell.com/legal/website-terms-use) | Copyright
© 2025 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FTSEELFBEVLBBBV